Unknown NA INTERVENTIONAL 3-arm NCT02008968

Effect of Allopurinol Treatment on Insulin Resistance

Sponsor: Istanbul Medeniyet University

Conditions Hyperuricemia Insulin Resistance Prediabetes

Interventions No intervention Normouricemic allopurinol 300 mg./day

Updated 7 times since 2017 Last updated: Dec 10, 2013 Started: Dec 31, 2013 Primary completion: Jul 31, 2014 Completion: Aug 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Hyperuricemia and Insulin Resistance and is currently ongoing. Istanbul Medeniyet University leads this study, which shows 7 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Jan 2026 — Present [monthly]

Unknown NA
Sep 2025 — Present [monthly]

Unknown NA
Sep 2024 — Sep 2025 [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

Dec 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Istanbul Medeniyet University

Data source: Istanbul Medeniyet University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Istanbul, Turkey (Türkiye)